洞察市场格局
解锁药品研发情报

客服电话

400-9696-311
医药数据查询

首页 临床进展 Dr. Judy Hayek, please contact us for uploading approved file of ethical committee. Minimally Invasive Versus Open Surgery for Women with Stage 1A1 and Stage 1A2 Cervical Cancer: a Medical Records Based Study

【ChiCTR2100050877】Dr. Judy Hayek, please contact us for uploading approved file of ethical committee. Minimally Invasive Versus Open Surgery for Women with Stage 1A1 and Stage 1A2 Cervical Cancer: a Medical Records Based Study

查看原文
立即下载
基本信息
登记号

ChiCTR2100050877

试验状态

尚未开始

药物名称

/

药物类型

/

规范名称

/

首次公示信息日的期

2021-09-05

临床申请受理号

/

靶点

/

适应症

Cervical Cancer

试验通俗题目

Dr. Judy Hayek, please contact us for uploading approved file of ethical committee. Minimally Invasive Versus Open Surgery for Women with Stage 1A1 and Stage 1A2 Cervical Cancer: a Medical Records Based Study

试验专业题目

Minimally Invasive Versus Open Surgery for Women with Stage 1A1 and Stage 1A2 Cervical Cancer

申办单位信息
申请人联系人
请登录查看
申请人名称
请登录查看
联系人邮箱
请登录查看
联系人邮编

11231

联系人通讯地址
请登录查看
临床试验信息
试验目的

Primary outcome: Comparing overall survival between patients undergoing minimally invasive (MIS) vs open surgical management, for treatment of cervical cancer stages IA1 and IA2 Secondary outcome: Comparing hospital stay after surgery, readmission and 90-day mortality for patients with cervical cancer stages IA1 and IA2 undergoing minimally invasive vs open surgical management.

试验分类
请登录查看
试验类型

连续入组

试验分期

回顾性研究

随机化

N/A

盲法

N/A

试验项目经费来源

Northwell Health

试验范围

/

目标入组人数

6230

实际入组人数

/

第一例入组时间

2010-09-01

试验终止时间

2016-12-31

是否属于一致性

/

入选标准

Patients with pathologically staged cervical cancer stages IA1 and IA2, who underwent simple, modified radical or radical hysterectomy as primary treatment between 2010-2016.；

排除标准

Patients who did not undergo surgery as primary treatment modality.；

研究者信息
研究负责人姓名
请登录查看
试验机构

Northwell Health

研究负责人电话
请登录查看
研究负责人邮箱
请登录查看
研究负责人邮编

10305

联系人通讯地址
请登录查看
更多信息
获取更多临床信息查看权限
立即前往摩熵医药企业版免费查询
示例数据
<END>

Northwell Health的其他临床试验

更多

Northwell Health的其他临床试验

更多

最新临床资讯

更多
摩熵医药企业版
50亿+条医药数据随时查
7天免费试用
体验产品

同适应症药物临床试验

更多